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To search for such TG lipases, we screened gene and protein databases for murine and human proteins with structural homologies to known lipases, i.e., the GXSXG motif for serine esterases and a/b hydrolase folds. Candidates were analyzed for TG-hydrolase activity and expression in mouse adipose tissue. Only one previously undescribed enzyme fulfilled these requirements, and we named it Badipose triglyceride lipase[ (ATGL).
The murine gene for ATGL (NCBI nucleotide entry AK031609) encodes a 486-amino acid protein (BAC27476) with a calculated molecular mass of 54 kD. The amino acid sequences of murine ATGL and two closely related proteins, NP_473429 (annotated as adiponutrin) and XP_128189 are shown in fig. S1 . The human ATGL gene, also designated TTS-2.2, encodes a 504-amino acid protein (NP_065109) with 86% identity to the mouse enzyme. The N-terminal regions of È260 residues in both the murine and the human enzyme contain a Bpredicted esterase of the a/b hydrolase fold[ domain (COG1752) (11) , as well as a GXSXG site with a putative active serine (amino acid 47). Moreover, a Bpatatin[ domain (Pfam01734) can be detected in the same region (12) . Patatin domain-containing proteins are commonly found in plant storage proteins such as the prototype patatin, an abundant protein of potato tubers (13) . These proteins have been shown to have acyl-hydrolase activity on phospholipid, monoglyceride, and DG substrates. Patatin-domains are also present in TGL3, a TG-lipase of Saccharomyces cerevisiae (14) , and human cytosolic phospholipase A2 (15) .
For ATGL, mRNA is expressed at high levels in murine white and brown adipose tissue (WAT and BAT, Fig. 1A ) and to a lesser degree in testis, cardiac muscle, and skeletal muscle. Highest expression of human ATGL (TTS-2.2) mRNA is also found in adipose tissue ( fig. S2 ). ATGL mRNA expression was first detected 4 days after induction of differentiation of murine 3T3-L1 adipocytes, and maximum expression was observed at day 6 ( virus-40-transformed monkey kidney cells (COS-7) with cDNA clones expressing either murine histidine (His)-tagged ATGL or murine His-tagged HSL. Both enzymes were detected in the cytosolic supernatant and the membrane pellet fraction of transfected COS-7 cells by Western blotting (Fig. 1C) . When extracts from transfected cells were preincubated with a fluorescent lipase inhibitor (NBD-HEHP) (16) and subsequently subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) analysis and fluorography (17) , fluorescent signals were observed in positions corresponding to the expected molecular mass of ATGL (54 kD) and HSL (84 kD), (Fig. 1C) . This fluorescent probe only reacts with enzymatically active Ser-lipases (16 ) which indicates that ATGL is enzymatically active in transfected COS-7 cells. To confirm this, we performed activity assays with radiolabeled lipid substrates ( Fig. 1D) (Fig. 1E ). Many TG lipases can hydrolyze more than one ester bond within the TG molecule, which results in the formation of monoglycerides or glycerol. For example, HSL cleaves TGs and DGs; however, its specific activity for DGs is 10 times that for TGs (20) . In contrast, ATGL exhibited only very weak activity against a radiolabeled DG substrate compared with the TG substrate ( Fig. 2A) . Low DG-hydrolase activity of ATGL was also confirmed in experiments in which we measured the relative abundance of lipolytic reaction products (Fig. 2B) (17) . Compared with control extracts of LacZtransfected COS-7 cells, extracts from ATGL and HSL-transfected cells showed higher acyl-hydrolase activities (FA release) by factors of 7.5 and 10, respectively, when a E9,10-3 H(N)^-labeled triolein-substrate was used. In the presence of ATGL, the accumulation of DGs was increased 21-fold, which suggests that the enzyme predominantly hydrolyzed the first ester bond of TGs. In contrast, no DG accumulation was observed in lipolysis assays with cytosolic extracts from HSLtransfected cells. Monoglyceride levels were slightly increased in both ATGL-and HSL-transfected cells. From the molar ratios of DG and MG accumulation versus FA release we calculated that È90% of the FA molecules released by the action of ATGL originate from the hydrolysis of TGs in the first ester bond. In contrast, in the presence of HSL, most FA originated from all three ester bonds resulting in glycerol formation. Thus, ATGL and HSL have different substrate-specificities within the lipolytic cascade, which suggests that they might act coordinately in the catabolism of TGs.
This hypothesis was confirmed by the product profiles generated in triolein hydrolysis assays using combined extracts of LacZ-, ATGL-, or HSL-transfected cells. Relative to extracts from LacZ-transfected cells, the acyl-hydrolase activity was increased in equal volume mixtures of HSL/LacZ extracts (4.8-fold), ATGL/LacZ extracts (4-fold), and ATGL/HSL extracts (16-fold) (Fig. 2C) . The accumulation of DGs was increased 12.5-fold when LacZ/ ATGL extracts were used and reduced to basal levels with ATGL/HSL extracts. We speculate that during the lipolytic breakdown of TGs, ATGL is predominantly responsible for the initial step of TG hydrolysis and provides DG substrate for the subsequent action of HSL, namely, the conversion of DGs into monoglycerides. In support of this model, the total acylhydrolase activity (FA release) in extracts containing ATGL/HSL was nearly 2 times the sum of the individual activities (Fig.  2C) . During the final step of lipolysis, monoglycerides are converted to FA and glycerol by monoglyceride lipase (21) .
The expected intracellular localization of a lipase involved in TG mobilization would be on lipid droplets. To determine whether this is true for ATGL, we constructed an adenovirus vector encoding His-tagged mouse ATGL and used it to infect 3T3-L1 adipocytes at day 8 of differentiation. Western blotting analysis revealed that the majority of ATGL protein (È50%) was present in the cytoplasm (Fig. 3A) . However, a distinct fraction of ATGL (È10%) was found tightly associated with lipid droplets of adipocytes even after extensive purification of the droplets. The amount of lipid dropletassociated ATGL was not affected by the stimulation of lipolysis with isoproterenol. In addition, fluorescence microscopy revealed that a green fluorescent protein-ATGL fusion protein localizes to the lipid droplet when expressed in 3T3-L1 adipocytes ( fig. S3) .
Further proof for a functional role of ATGL as a TG-hydrolase was provided by the fact that adenovirus-infected 3T3-L1 cells expressing ATGL released higher levels of FA (5-fold) and glycerol (1.8-fold) compared with LacZ-infected cells under basal conditions (Fig. 3B) . After isoproterenol stimulation, FA release was increased 1.8-fold and glycerol release 2.9-fold. Additionally, ATGL-overexpression caused an increase in the cellular steady-state levels of DGs ( fig. S4 ). Thus, ATGL in adipocytes can markedly augment both basal and isoproterenol-stimulated lipolysis. In contrast, silencing ATGL gene expression by siRNA (Fig. 3C) or antisense-RNA (fig. S5 ) markedly decreased the release of FA and glycerol from stimulated and nonstimulated 3T3-L1 adipocytes.
We next tested the effect of a rabbit polyclonal antibody against mouse ATGL (ATGL-IgG) on the enzyme activity of adipose tissue extracts from wild-type and HSL-deficient mice. In comparison with rabbit nonimmune IgG (NI-IgG), ATGLIgG inhibited the cytosolic acyl-hydrolase activity in white and brown fat of wildtype mice by 64% and 71%, respectively (Fig. 3D) . In white and brown adipose tissue of HSL-deficient mice, the activity was decreased by 75% and 74%, respectively. Thus the combined deficiency of HSL and ATGL in adipose tissue causes a loss of more than 90% of the acylhydrolase activity observed in wild-type adipose tissue. Compared with wild-type adipose tissue, the ATGL-mediated acylhydrolase activity and ATGL mRNA levels were not up-regulated in HSL-deficient adipose tissue (22) .
Considering the central role of PKA in the regulation of fat cell lipolysis we tested whether ATGL is a target for PKA-mediated phosphorylation. As described in SOM ( fig.  S6 ), ATGL can be phosphorylated, but in contrast to HSL, this modification is not mediated by PKA.
In summary, our findings suggest that ATGL is an important component of the lipolytic process and the mobilization of lipid stores in mammals. It is responsible for the initial step in TG catabolism. Accordingly, the inhibition of ATGL offers a potential therapeutic approach to control FA release from adipose tissue in patients with insulin resistance.
Note added in proof: Two manuscripts in press present findings that the hormonally and nutritionally regulated protein desnutrin (23) and the TG-hydrolace inducible phospholipase-A2-K (24) are identical to ATGL. 
